Skip to main content

Table 1 Baseline characteristics of the included studies

From: Lymphopenia in severe coronavirus disease-2019 (COVID-19): systematic review and meta-analysis

Author

Study design

Country

Sample (n)

Gender (male %)

Age (years)

Cardiac comorbidity (%)

HT (%)

DM (%)

Ruan et al. 2020 [7]

Retrospective

Wuhan, China

150

102/150 (68%)

67 non-survivor and 50 survivor (median)

8.7

34.7

16.7

Yang et al. 2020 [6]

Retrospective

Wuhan, China

52

35/52 (67%)

59.7 (mean)

9.6

NR

17.3

Zhou et al. 2020 [20]

Retrospective

Wuhan, China

191

119/191 (62%)

56 (median)

7.9

30.4

18.8

Chen et al. 2020 [23]

Retrospective

Wuhan, China

124

61/124 (49%)

72 non-survivor and 53 survivor (median)

16.1

33.1

11.3

Huang et al. 2020 [5]

Retrospective

Wuhan, China

41

30/41 (73%)

49 (median)

14.6

14.6

19.5

Wang et al. 2020 [24]

Retrospective

Wuhan, China

138

75/138 (54%)

56 (median)

14.5

31.2

10.1

Cao et al. 2020 [25]

Retrospective

Shanghai, China

198

101/198 (51%)

50.1 (mean)

6.1

21.2

7.6

Wu et al. 2020 [26]

Retrospective

Wuhan, China

201

30/41 (73%)

51 (median)

4.0

19.4

10.9

Yanli et al. 2020 [27]

Retrospective

Wuhan, China

109

59/109 (54%)

55 (median)

6.4

33.9

11.0

Guan et al. 2020 [28]

Retrospective

Wuhan, China

1099

640/1099 (58%)

47 (median)

2.5

15.0

7.4

Liu et al. 2020 [29]

Retrospective

Wuhan, China

78

39 (58%)

38 (median)

NR

10.3

6.4

Zhang G et al 2020 [10]

Retrospective

Wuhan, China

221

108/221 (48.9%)

55 (median)

10.0

24.4

10.0

Zhang et al. 2020 [11]

Retrospective

Wuhan, China

140

71/140 (50.7%)

57 (median)

5.0

30.0

12.1

Wan et al. 2020 [12]

Retrospective

Chongqing, China

135

72/135 (53.3%)

47 (median)

5.0

9.6

8.9

Qu et al. 2020 [13]

Retrospective

Huizhoi, China

30

16/30 (53.3%)

50.5 (median)

NR

NR

NR

Qin et al. 2020 [14]

Retrospective

Wuhan, China

452

235/ 452 (52%)

58 (median)

6.0

29.9

16.6

Wang et al. 2020 [15]

Retrospective

Wuhan, China

110

48/110 (43%)

≤ 40 (53%), 41–60 (21%), > 60 (36%)

6.4

20.9

13.6

Feng et al. 2020 [16]

Retrospective

Wuhan, China

141

72/141 (51.1%)

44 (median)

2.7

14.9

5.7

Lei et al. 2020 [17]

Retrospective

Chongqing, China

51

32/51 (62.7%)

45 (median)

NR

7.8

7.8

Liu et al. 2020 [18]

Retrospective

Wuhan, China

40

15/40 (37.5%)

48.7 (mean)

NR

15.0

15.0

Cai et al. 2020 [19]

Retrospective

Shenzhen, China

298

149/298 (50%)

47 (median)

NR

NR

NR

Liu et al. 2020 [21]

Prospective

Beijing, China

61

31/61 (50.8)

40 (median)

1.6

19.7

8.2

Tabata et al. 2020 [22]

Retrospective

Tokyo, Japan

104

47/104 (45%)

68 (median)

NR

NR

NR

  1. NR not reported, DM diabetes mellitus, HT hypertension